coronavirus treatment

If approved for use, the pills would add an easy-to-use weapon to the arsenal against the coronavirus pandemic.

The pharmaceutical company announced that its experimental pill reduced hospitalizations and deaths by half in people infected with the coronavirus. The findings are not peer reviewed.

At least three promising antiviral treatments for COVID-19 are being tested in clinical trials, with results expected as soon as late fall or winter.

Gov. Ron DeSantis said the state will receive 3,000 doses of sotrovimab, which received emergency use authorization in May, as the Biden administration begins rationing antibody treatments to Florida.

With the surge in cases, one treatment for extremely sick patients is getting really hard to find. It's called extracorporeal membrane oxygenation, and it's a bypass machine for the heart and lungs.

Locations in Pasco, Hillsborough and Volusia counties join five others around the state. Patients at high-risk of developing severe COVID-19 including those with obesity or lung disease can get the treatment.

The treatment is proving to be an effective tool at preventing severe illness, but patients who test positive for COVID-19 have to get it early in order for it to work well.

The drug combination from Regeneron Pharmaceuticals cut patient deaths from 30% to 24% among those who hadn’t already developed an immune response against COVID-19.

Philanthropies are funding studies of cheap, existing meds like fluvoxamine as treatments. But early hype about hydroxychloroquine and other drugs leaves researchers leery of hasty conclusions.

Regeneron says tests in more than 4,000 recently diagnosed patients found its two-antibody combo drug cut the risk of hospitalization or death by 70%.